Post by
Smokey1958 on Jan 05, 2022 9:24am
THRM is Doing It Right....
....even if being forced to take the long route to get there. Of the last handful of rapid antigen tests receiving an FDA EUA for the first time all have included a "Home" designation ....meaning they can be sold and used as an over the counter device. So, while it can be tough waiting, imho one can be reassured by the fact that this latest testing was done to include that sole purpose. Will laymen collecting the sample and using the device be able to achieve equally accurate results as those carried out by a trained health professional?
It seems to mean this is not only the final hurdle but all or nothing. If the results are quantitatively similar to the in vitro and Brazil test conclusions there is no other obstacle to approval.
Morningstar's Fair Value sp is in line with this as it sits at $1.14 this morning. Barchart sentiment is also moving in the same direction with a 24% BUY today after a 64% SELL a month ago and a 16% BUY yesterday. The greatest support has moved up to $.41 and the resistance levels have converged between $.435 and $.46 ...any kind of run should see these breached.
GLTE ....the reward should be well worth the wait!!! Imagine the state of management with everything now left to the hands of others.